Quantcast

Latest Plateletpheresis Stories

2009-01-13 09:42:00

Recession, Winter Weather Compound January's Blood Drain NEW YORK, Jan. 13 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC) and its regional operations (serving New York City, Long Island, Hudson Valley and New Jersey) have issued an emergency appeal for blood donations. Hospital demand for blood (needed for emergency care and surgery) has increased beyond seasonal expectations while levels of blood donation have been below forecast. Blood supplies have dropped below the five-day...

2009-01-05 16:00:00

Critical need to restore community blood supply NEW YORK, Jan. 5 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC) calls upon the community to please donate blood today, in recognition of National Blood Donor Month, and to help replenish the local blood supply that has fallen sharply over the recent holiday period. Supplies of many blood types are now at the critical 3-day level, with distribution restrictions placed on Type O, Rh negative blood. Ordinarily, a 5-7 day supply is...

2008-12-23 11:12:12

It might be possible to grow human blood platelets in the laboratory for transfusion, according to a new study at The Ohio State University Medical Center. The findings, published in the January 1, 2009 issue of the journal Experimental Hematology, might one day enable blood banks to grow platelets continuously and in quantities that can ease the chronically tight supply of these critical blood components. About 13 million platelet concentrates are collected annually in the United States at a...

2008-12-06 11:00:00

SAN FRANCISCO, Dec. 6 /PRNewswire-USNewswire/ -- Four studies that highlight significant advances in treatment and survival outcomes for patients with various forms of thrombocytopenia, a group of bleeding disorders characterized by a low number of platelets in the blood, will be presented in a press conference on Saturday, December 6, at 8:00 a.m., during the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA. The studies featured in the press conference will...

2008-12-06 10:00:00

PHILADELPHIA, Dec. 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced positive safety and efficacy results from RAISE (RAndomized placebo- controlled ITP Study with Eltrombopag), a Phase III study of PROMACTA(R) (eltrombopag) in adults with chronic immune (idiopathic) thrombocytopenic purpura (ITP) who had received one or more prior ITP therapies. Patients receiving PROMACTA were eight times more likely than those on placebo to maintain platelet counts between 50,000 to...

2008-12-04 09:29:00

People with Rare Anemias, Blood Cancers Need You NEW YORK, Dec. 4 /PRNewswire-USNewswire/ -- As winter holidays fast approach, New York Blood Center (NYBC) calls upon the community to please set aside a time to donate blood. The holidays are a time when blood supply decreases while emergency needs remain the same. It is also a time when it becomes more difficult to find precise blood matches for those that are very sick. December is also Aplastic Anemia Awareness Month. Aplastic anemia...

2008-09-03 18:00:41

MEDIA ADVISORY: WHAT: Officials from the U.S. Food and Drug Administration Blood Products Advisory Committee (BPAC) will meet with government institutions and top experts from academia and private industry on September 10, 11 and 12 in two separate meetings to address issues related to safety of the blood supply including: -- Bacterial contamination of donated blood products for transfusion which can lead to sepsis (Sept. 10) -- Risk of infectious disease such as malaria from blood...

2008-08-30 09:01:03

By Risha Chitlangia New Delhi: Keeping in mind the rising number of dengue cases and the corresponding demand for platelets, the Delhi government is planning to make platelets available free of cost during the dengue season. Health minister Dr Yoganand Shastri has directed the state blood transfusion department to moot a proposal for the same, which sources say has got an in-principle approval. The Delhi government has three centres which have platelet separator machines through which...

2008-08-25 09:00:26

The U.S. Food and Drug Administration says it has approved Nplate (romiplostim), the first product that directly stimulates bone marrow platelet production. The FDA said the new drug will be used to produce needed platelets in patients with a rare blood disorder that can lead to serious bleeding. The condition, which usually develops in adults, is known as chronic immune thrombocytopenic purpura, or ITP, a disease that results in a low number of platelets, the blood components that help...

2008-08-22 15:00:51

Amgen Inc. (NASDAQ: AMGN) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nplate(TM) (romiplostim), the first and only platelet producer for the treatment of thrombocytopenia in splenectomized (spleen removed) and non-splenectomized adults with chronic immune thrombocytopenic purpura (ITP). Nplate, the first FDA-approved peptibody protein, works by raising and sustaining platelet counts, representing a novel approach for the long-term treatment of...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related